NASDAQ:SDGR Schrödinger (SDGR) Stock Price, News & Analysis $20.50 -0.02 (-0.10%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$20.04▼$20.8150-Day Range$18.05▼$24.0252-Week Range$18.02▼$38.00Volume596,383 shsAverage Volume510,571 shsMarket Capitalization$1.49 billionP/E RatioN/ADividend YieldN/APrice Target$33.44 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Schrödinger alerts: Email Address Schrödinger MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside63.1% Upside$33.44 Price TargetShort InterestBearish11.57% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.19) to ($2.14) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.46 out of 5 starsMedical Sector665th out of 910 stocksPharmaceutical Preparations Industry307th out of 426 stocks 3.4 Analyst's Opinion Consensus RatingSchrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageSchrödinger has only been the subject of 4 research reports in the past 90 days.Read more about Schrödinger's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted11.57% of the outstanding shares of Schrödinger have been sold short.Short Interest Ratio / Days to CoverSchrödinger has a short interest ratio ("days to cover") of 12, which indicates bearish sentiment.Change versus previous monthShort interest in Schrödinger has recently increased by 5.26%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSchrödinger does not currently pay a dividend.Dividend GrowthSchrödinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SDGR. Previous Next 3.3 News and Social Media Coverage News SentimentSchrödinger has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Schrödinger this week, compared to 3 articles on an average week.Search Interest11 people have searched for SDGR on MarketBeat in the last 30 days. This is an increase of 83% compared to the previous 30 days.MarketBeat Follows4 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Schrödinger insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.60% of the stock of Schrödinger is held by insiders.Percentage Held by Institutions79.05% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Schrödinger's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Schrödinger are expected to grow in the coming year, from ($2.19) to ($2.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrödinger is -10.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrödinger is -10.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSchrödinger has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Schrödinger's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Schrödinger Stock (NASDAQ:SDGR)Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.Read More SDGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SDGR Stock News HeadlinesSeptember 5 at 1:37 AM | americanbankingnews.comComparing Schrödinger (NASDAQ:SDGR) & Emmaus Life Sciences (OTCMKTS:EMMA)August 28, 2024 | msn.comSchrödinger, Inc. (SDGR): Among The Best Medical AI CompaniesSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 5, 2024 | investorplace.comThe 3 Best Med Tech Stocks to Buy NowAugust 1, 2024 | msn.comSchrödinger, Inc. (NASDAQ:SDGR) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | markets.businessinsider.comStrong Performance and Growth Potential Affirm Schrodinger’s Buy RatingJuly 31, 2024 | msn.comSchrödinger Non-GAAP EPS of -$0.66 beats by $0.23, revenue of $47.3M beats by $7.7MJuly 31, 2024 | finance.yahoo.comSchrödinger Reports Strong Second Quarter 2024 Financial ResultsSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. July 27, 2024 | investorplace.com3 Small-Cap Stocks to Buy at a 52-Week LowJuly 26, 2024 | stockhouse.comSchrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive ToxicologyJuly 23, 2024 | finance.yahoo.comWe're Not Very Worried About Schrödinger's (NASDAQ:SDGR) Cash Burn RateJuly 22, 2024 | investorplace.com3 Stocks That Could Benefit Big Time From Coming Interest Rate CutsJuly 19, 2024 | finance.yahoo.comSchrödinger to Announce Second Quarter 2024 Financial Results on July 31July 3, 2024 | investorplace.com3 Top-Rated Gene Editing Stocks Actually Making MoneyJune 14, 2024 | businesswire.comSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)June 4, 2024 | seekingalpha.comSchrodinger: Buy The Drug-Discovery Platform And Get The Pipeline Nearly For FreeJune 1, 2024 | 247wallst.com1 Growth Stock That Could Dominate AI's Next BreakthroughSee More Headlines Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SDGR CUSIPN/A CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees867Year FoundedN/APrice Target and Rating Average Stock Price Target$33.44 High Stock Price Target$50.00 Low Stock Price Target$25.00 Potential Upside/Downside+63.1%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($1.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$40.72 million Net Margins-100.42% Pretax Margin-102.01% Return on Equity-38.38% Return on Assets-26.66% Debt Debt-to-Equity RatioN/A Current Ratio4.50 Quick Ratio4.50 Sales & Book Value Annual Sales$216.67 million Price / Sales6.89 Cash Flow$0.65 per share Price / Cash Flow31.73 Book Value$6.51 per share Price / Book3.15Miscellaneous Outstanding Shares72,800,000Free Float66,429,000Market Cap$1.49 billion OptionableOptionable Beta1.51 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Ramy Farid Ph.D. (Age 59)CEO, President & Director Comp: $1.06MDr. Richard A. Friesner Ph.D. (Age 71)Co-Founder, Scientific Advisory Chairman and Director Comp: $465kDr. Geoffrey Craig Porges MBBSExecutive VP & CFODr. Robert Lorne Abel Ph.D. (Age 42)Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Comp: $569.45kDr. Karen Akinsanya Ph.D. (Age 56)President of Research & Development Therapeutics Comp: $797.74kDr. Margaret Han Dugan M.D. (Age 67)Chief Medical Officer Comp: $707.46kProf. William Goddard IIICo-Founder & Scientific AdvisorMr. Kenneth Patrick Lorton (Age 40)Executive VP, CTO & COO of Software Comp: $510.09kMr. Shane Brauner (Age 46)Executive VP & Chief Information Officer Ms. Jaren Irene MaddenSenior Vice President of Investor Relations & Corporate CommunicationsMore ExecutivesKey CompetitorsSage TherapeuticsNASDAQ:SAGEEmergent BioSolutionsNYSE:EBSAllakosNASDAQ:ALLKTurning Point TherapeuticsNASDAQ:TPTXForty SevenNASDAQ:FTSVView All CompetitorsInsiders & InstitutionsAlgert Global LLCBought 62,010 shares on 8/16/2024Ownership: 0.120%Creative PlanningBought 21,976 shares on 8/16/2024Ownership: 0.030%Capital Impact Advisors LLCSold 2,593 shares on 8/16/2024Ownership: 0.018%The Manufacturers Life Insurance Company Sold 885 shares on 8/15/2024Ownership: 0.040%Deerfield Management Company L.P. Series CBought 16,428 shares on 8/15/2024Ownership: 0.023%View All Insider TransactionsView All Institutional Transactions SDGR Stock Analysis - Frequently Asked Questions How have SDGR shares performed this year? Schrödinger's stock was trading at $35.80 at the start of the year. Since then, SDGR stock has decreased by 42.7% and is now trading at $20.50. View the best growth stocks for 2024 here. How were Schrödinger's earnings last quarter? Schrödinger, Inc. (NASDAQ:SDGR) released its earnings results on Wednesday, February, 28th. The company reported ($0.32) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.12. The company's revenue was up 30.5% compared to the same quarter last year. What is Ramy Farid's approval rating as Schrödinger's CEO? 8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. When did Schrödinger IPO? Schrödinger (SDGR) raised $150 million in an initial public offering on Thursday, February 6th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO. Who are Schrödinger's major shareholders? Top institutional shareholders of Schrödinger include Rubric Capital Management LP (4.30%), ARK Investment Management LLC (3.37%), Sumitomo Mitsui Trust Holdings Inc. (2.97%) and Baillie Gifford & Co. (2.92%). Insiders that own company stock include Ramy Farid, Kenneth Patrick Lorton, Yvonne Tran, Jenny Herman, Robert Lorne Abel, Nancy Thornberry and Karen Akinsanya. View institutional ownership trends. How do I buy shares of Schrödinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Schrödinger own? Based on aggregate information from My MarketBeat watchlists, some other companies that Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ) and Cisco Systems (CSCO). This page (NASDAQ:SDGR) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrödinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schrödinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.